FDA Inspection 1258048 — Boehringer Ingelheim RCV GmbH & Co KG
The FDA completed an inspection of Boehringer Ingelheim RCV GmbH & Co KG on Nov 12, 2024 in Vienna. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 12, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Vienna (Austria)